- Immune checkpoint inhibitor-induced acute tubulointerstitial nephritis
-
Tan HZ, Lee JJX, Choo CJJ, Loh AHL
- KMID: 2526550
- Kidney Res Clin Pract.
- 2022 Jan;41(1):128-131.
- doi: 10.23876/j.krcp.21.216
-
- CITED
-
- Close
- SHARE
-
- Close
- Synergistic impact of pre-diabetes and immunosuppressants on the risk of diabetes mellitus during treatment of glomerulonephritis and renal vasculitis
-
Lim CC, Gardner D, Ng RZ, Chin YM, Tan HZ, Mok IY, Choo JC
- KMID: 2503862
- Kidney Res Clin Pract.
- 2020 Jun;39(2):172-179.
- doi: 10.23876/j.krcp.20.024
Background: Glomerulonephritis is often treated with kidney-saving, but potentially diabetogenic immunosuppressants such as glucocorticosteroids and calcineurin inhibitors. Unfortunately, there are little data on dysglycemia before and after diagnosis and during... -
- CITED
-
- Close
- SHARE
-
- Close
- Changes in metabolic parameters and adverse kidney and cardiovascular events during glomerulonephritis and renal vasculitis treatment in patients with and without diabetes mellitus
-
Lim CC, Choo JCJ, Tan HZ, Mok IYJ, Chin YM, Chan CM, Woo KT
- KMID: 2520041
- Kidney Res Clin Pract.
- 2021 Jun;40(2):250-262.
- doi: 10.23876/j.krcp.20.174
Background: Cardiovascular disease causes significant morbidity and mortality in patients with glomerulonephritis, which is increasingly diagnosed in older individuals who may have diabetes mellitus (DM). We evaluated the impact of... -
- CITED
-
- Close
- SHARE
-
- Close
